SirYus technology targets high-growth segments of the in vitro diagnostics markets, and aims to provide a fully automated multiplex diagnostic tools answering the needs of healthcare professionals.
The in vitro diagnostics market is evaluated at 40 billion dollars a year and grows at a 5% rate worldwide.
SirYus technology targets the oncology, blood screening, infectiology and transplantation markets, that represent together about 50 % of the total valuation.
A concentrated market
15 companies account for 90 % of the In Vitro Diagnotics market, providing large opportunities for the SirYus ltechnology licencing.
A high-growth market
US and Europe markets grow at a constant rate of 5 % while Asian markets demonstrate very high growth (+ 25 % in China for example).